FDA authorizes Novavax Covid vaccine targeting JN.1
A vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. Dado Ruvic | ReutersThe Food and Drug Administration authorized Novavax's updated protein-based Covid vaccine for emergency use in people ages 12 and up on Friday, paving the way for the shot to compete with...